| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Precigen, Inc. (PGEN) has 13 insiders with recent SEC Form 4 filings, including 1 buy and 0 sells. PGEN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.77M | $20.45M | -119,250 | |
| Other | 755.5K | $4.10M | -29,131 | |
| Dir | 613.6K | $3.33M | - | |
| CFO | 554.5K | $3.01M | -41,884 | |
| COO | 497.8K | $2.70M | -42,703 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2015 | Kirk Randal J | 10% Owner | Buy | 13,939,392 | $0.17 | $2,299,999.68 | +58.1% |